AAAAI & ACAAI GUIDELINES Bundle (free trial)

Anaphylaxis 2016

AAAAI & ACAAI GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: http://eguideline.guidelinecentral.com/i/636525

Contents of this Issue

Navigation

Page 27 of 27

Disclaimer is Guideline attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Source Lieberman P, Nicklas RA, Randolph C, Oppenheimer J, Bernstein D, Bernstein J, Ellis A, Golden DB, Greenberger P, Kemp S, Khan D, Ledford D, Lieberman J, Metcalfe D, Nowak-Wegrzyn A, Sicherer S, Wallace D, Blessing-Moore J, Lang D, Portnoy JM, Schuller D, Spector S, Tilles SA. Anaphylaxis-a practice parameter update 2015. Ann Allerg y Asthma Immunol. 2015 Nov;115(5):341-84. 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies, at GuidelineCentral.com Copyright © 2016 All rights reserved AAAAIANA15123a Abbreviations ACE inhibitors, angiotensin-converting enzyme inhibitors; AHNMD, ssociated with lymphoproliferative disorders; AIE, auto-injectable epinephrine; AIT, allergen immunotherapy; alpha-gal, galactose-a-1,3-galactose; EIA, exercise-induced anaphylaxis; EMS, emergency medical services; FAAN, Food Allerg y and Anaphylaxis Network (now Food Allerg y; Research & Education); FDEIA, food-dependent exercise-induced anaphylaxis; MCAS, mast cell activating syndrome; MMAS, monoclonal mast cell activating syndrome; NIAID, National Institute of Allerg y and Infectious Diseases; NL, normal; NSAID, nonsteroidal anti-inflammatory drug ; RCM, radiocontrast material; SCIT, subcutaneous immunotherapy; SM, systemic mastocytosis; SR, systemic reaction; SS, summary statement: UP, urticaria pigmentosa; VIT, venom immunotherapy; WHO, World Health Organization

Articles in this issue

Links on this page

Archives of this issue

view archives of AAAAI & ACAAI GUIDELINES Bundle (free trial) - Anaphylaxis 2016